Hikma Pharmaceuticals Plc (OTCMKTS:HKMPF – Get Free Report)’s stock price gapped down prior to trading on Friday . The stock had previously closed at $23.1750, but opened at $20.49. Hikma Pharmaceuticals shares last traded at $20.49, with a volume of 100 shares.
Hikma Pharmaceuticals Stock Performance
The firm has a 50 day moving average price of $23.37 and a two-hundred day moving average price of $25.62. The company has a quick ratio of 0.72, a current ratio of 1.24 and a debt-to-equity ratio of 0.33.
Hikma Pharmaceuticals Company Profile
Hikma Pharmaceuticals PLC develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment provides generic injectable products primarily for use in hospitals.
Featured Stories
- Five stocks we like better than Hikma Pharmaceuticals
- Stock Splits, Do They Really Impact Investors?
- Amgen Stock: New All-Time Highs Ahead After Earnings Beat
- What is the Shanghai Stock Exchange Composite Index?
- Netflix Stock Split Explained: What It Means for Investors
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- SoundHound Beat Earnings & Dropped—Here’s What Wall Street Missed
Receive News & Ratings for Hikma Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hikma Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
